Bio-Works Receives Order for 22,6 MSEK from Returning Customer
Igår, 08:17
Bio-Works Receives Order for 22,6 MSEK from Returning Customer
Bio-Works Technologies AB has received a new order from a returning customer with an order value of 22,6 MSEK. The order relates to the delivery of the company’s chromatography products and further strengthens the ongoing collaboration between the parties.
The order will be delivered as planned during Q4 2026, and Q2, 2027.
Contact
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, email: lone.carlbom@bio-works.com (lone.carlbom@bio-works.com), phone: +46(0)8-502 705 84.
About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.
Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 17-07-2026 08:17 CET.
Ämnen i artikeln
Bio-Works Receives Order for 22,6 MSEK from Returning Customer
Igår, 08:17
Bio-Works Receives Order for 22,6 MSEK from Returning Customer
Bio-Works Technologies AB has received a new order from a returning customer with an order value of 22,6 MSEK. The order relates to the delivery of the company’s chromatography products and further strengthens the ongoing collaboration between the parties.
The order will be delivered as planned during Q4 2026, and Q2, 2027.
Contact
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, email: lone.carlbom@bio-works.com (lone.carlbom@bio-works.com), phone: +46(0)8-502 705 84.
About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.
Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 17-07-2026 08:17 CET.
Ämnen i artikeln
Aktieanalys
Saab
Rapporter i urval
Mildef
Rapporter i urval
Aktieanalys
Saab
Rapporter i urval
Mildef
Rapporter i urval
Marknadsöversikt
1 DAG %
Senast
1 mån
